Making Sense of Weight-Loss Drugs’ Cost and Coverage
WSJ Your Money Briefing
00:00
Understanding GLP-1 Drug Coverage and Future Prospects
This chapter examines the current state of employer coverage for GLP-1 drugs for weight loss in the U.S., noting that 36% provide such coverage. It also explores conditions employers may impose, future Medicare changes, and the potential impact of generics and recent policies on drug pricing.
Transcript
Play full episode
